GILLETTE INDIA
|
|
BOM : 507815     NSE : GILLETTE     | |
LT :  
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive] Debt : Low |
Updated: |
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Upward Pledged Shares : None or < 25% |
Nov 27,2024 |
Price(EOD): ₹ 9,875.70
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
|
Household & Personal Products |
MCap: ₹ 32,194.78 Cr |
Industry Peers & Returns | 1W | 1M | 1Y |
GILLETTE INDIA | 7.6% | 20.3% | 56.7% |
HINDUSTAN UNILEVER | 4.4% | -1.5% | -1.7% |
GODREJ CONSUMER PRODUCTS | 6.9% | -2.5% | 23% |
DABUR INDIA | 4.3% | -2.1% | -2.9% |
COLGATEPALMOLIVE (INDIA) | 12.2% | -2% | 35.9% |
PROCTER & GAMBLE HYGIENE AND HEALTH CARE | 0.2% | -0.4% | -11.4% |
EMAMI | 4% | 2.4% | 34% |
JYOTHY LABS | 0.6% | -16.2% | -8.8% |
SHEELA FOAM | 4.2% | -1.1% | -29.7% |
FUNDAMENTAL ANALYSIS OF GILLETTE INDIA
 Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
VALUATION OF GILLETTE INDIA
 Ratio | Standalone | |
---|---|---|
P/E P/B P/S |
71.19
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 452.02 Cr
[Latest Qtr - Sep2024 - Standalone Results ] 33.92
P/B Calculated based on Book Value of Rs 948.73 Cr
[Latest Year - Jun2024 - Standalone Results ] 11.71
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 0.00 Cr
[Latest Qtr - Sep2024 - Standalone Results ] |
|
Financial Ratios → |
Model | Discount(-)/ Premium(+) |
---|---|
EV/EBIDTA EV/Sales Price/Sales |
52% 46% 44% |
SHARE PRICE MOMENTUM OF GILLETTE INDIA
GILLETTE INDIA vs SENSEX
DEBT OF GILLETTE INDIA
Year | Debt/Equity ratio | |
---|---|---|
Standalone | Consolidated | |
2024 2023 2022 Avg_3yrs |
0 0 0 - |
- - - - |
[Last Annual Data : Jun2024]
|
||
Financial Ratios → |
PLEDGED PROMOTER SHARES OF GILLETTE INDIA
Pledged Promoter Shares |
0 % | |
---|---|---|
As on : Dec2023 | ||
If less than 25% | Good |
|
If between 25% and 50% | Neutral | |
If greater than 50% | Bad | |
Shareholding Pattern → |
QTRLY RESULTS OF GILLETTE INDIA
Standalone | Q-o-Q | Y-o-Y |
---|---|---|
Revenue Op Profit Profit Before Tax Profit After Tax |
21.15% 9.14% 14.19% 14.69% |
17.12% 38.31% 41.62% 43.5% |
QtrlyTrend |
8 | |
Latest Qtr: Sep2024 | ||
Quarterly Result Analysis → |
GILLETTE INDIA related INDICES
BSE Indices | 1W | 1M | 1Y |
---|---|---|---|
S&P BSE 250 SMALLCAP | 3.9% | 0.2% | 33.3% |
S&P BSE MIDSMALLCAP | 3.5% | 0.7% | 37.3% |
S&P BSE 400 MIDSMALLCAP | 3.4% | -0.2% | 35% |
S&P BSE QUALITY | 3.4% | -4.4% | 35% |
S&P BSE 500 | 3.1% | -0.5% | 28.2% |
NSE Indices | 1W | 1M | 1Y |
---|---|---|---|
NIFTY SMALLCAP250 | 4.2% | 1.2% | 35% |
NIFTY MID SMALL400 | 3.3% | 0.1% | 34.1% |
NIFTY500 MULTICAP 50:25:25 | 3.3% | -0.2% | 30.6% |
NIFTY 500 | 3.1% | -0.4% | 28.7% |
You may also like the below Video Courses
FAQ about GILLETTE INDIA
Is GILLETTE INDIA good for long term investment?
As on Nov 27,2024, the Fundamentals of GILLETTE INDIA look Strong and hence it may be good for long term investment! See Financial Performance of GILLETTE INDIA . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!Is GILLETTE INDIA UnderValued or OverValued?
As on Nov 27,2024, GILLETTE INDIA is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!What is the Intrinsic Value of GILLETTE INDIA ?
As on Nov 27,2024, the Intrinsic Value of GILLETTE INDIA is Rs. 6,779.72 estimated based on Median of the 3 historical models.Fair Value [Median EV / EBIDTA Model] : Rs. 6,496.99
Fair Value [Median EV / Sales Model] : Rs. 6,779.72
Fair Value [Median Price / Sales Model] : Rs. 6,874.11
Estimated Median Fair Value of GILLETTE INDIA : Rs. 6,779.72
The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.